We provide robust whole-genome sequencing (WGS) and targeted sequencing solutions for precise identification, typing, and characterization of bacteria, viruses, fungi, and other pathogens. Our long-read sequencing capabilities are particularly advantageous for resolving complex genomic regions, structural variants, and tracking outbreak dynamics.
Utilizing advanced RNA sequencing (RNA-seq), we enable in-depth analysis of gene expression patterns in host cells during infection. This allows for the identification of key pathways involved in immune response, disease progression, and therapeutic efficacy, providing crucial insights into the molecular mechanisms of infection.
The microbiome plays a significant role in health and disease, including susceptibility to and outcomes of infectious diseases. OHMX.bio offers comprehensive microbiome analysis services, including full-length 16S rRNA gene sequencing and metagenomics, to characterize microbial communities, identify dysbiosis, and explore their impact on infection.
Our expertise extends to the discovery and validation of novel biomarkers for infectious diseases. Leveraging NGS-based approaches, we can identify genetic, transcriptomic, and epigenetic markers that serve as indicators of infection, disease severity, treatment response, and patient stratification. Our capabilities support the translation of these biomarkers from discovery to clinical application.
